154 related articles for article (PubMed ID: 6247869)
1. Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyrapone.
de Lange WE; Sluiter WJ; Pratt JJ; Doorenbos H
Acta Endocrinol (Copenh); 1980 Apr; 93(4):488-94. PubMed ID: 6247869
[TBL] [Abstract][Full Text] [Related]
2. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
Matsuki M; Nishida S; Horino M; Tenku A; Oyama H
Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
[TBL] [Abstract][Full Text] [Related]
3. Improved single-dose metyrapone test.
Dickstein G; Barzilai D
Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
[TBL] [Abstract][Full Text] [Related]
4. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion.
Masi AT; Josipović DB; Jefferson WE
Semin Arthritis Rheum; 1984 Aug; 14(1):1-23. PubMed ID: 6091273
[TBL] [Abstract][Full Text] [Related]
5. [The discrepancy between ACTH and 11-deoxycortisol levels in a single dose metyrapone test].
Matsuki M
Nihon Naibunpi Gakkai Zasshi; 1983 Feb; 59(2):122-30. PubMed ID: 6303868
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the three hour metyrapone test in adults.
Best JD; Alford FP; Donald RA
Clin Endocrinol (Oxf); 1980 Jul; 13(1):69-76. PubMed ID: 6254698
[TBL] [Abstract][Full Text] [Related]
7. [Plasma 11-deoxycortisol response to single dose metyrapone in prostatic cancer patients (author's transl)].
Ohashi T; Morioka M; Akaeda T; Mitsuhata N; Takeda K; Ohmori H; Saito T; Takami T; Kanbegawa A
Nihon Naibunpi Gakkai Zasshi; 1981 Jul; 57(7):983-96. PubMed ID: 6269918
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal function in extrinsic asthma.
Morrish DW; Sproule BJ; Aaron TH; Outhet D; Crockford PM
Chest; 1979 Feb; 75(2):161-6. PubMed ID: 217570
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
Nelson JC; Tindall DJ
Am J Med Sci; 1978; 275(2):165-72. PubMed ID: 208417
[TBL] [Abstract][Full Text] [Related]
10. Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve.
Dickstein G; Lahav M; Orr ZS
Acta Endocrinol (Copenh); 1986 May; 112(1):28-34. PubMed ID: 3716755
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
Thorén M; Stenfors C; Apéria B; Mathé AA
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):319-26. PubMed ID: 2359842
[TBL] [Abstract][Full Text] [Related]
12. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
[TBL] [Abstract][Full Text] [Related]
13. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
Plonk J; Feldman J
J Clin Endocrinol Metab; 1976 Feb; 42(2):291-5. PubMed ID: 177441
[TBL] [Abstract][Full Text] [Related]
14. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency.
Dolman LI; Nolan G; Jubiz W
JAMA; 1979 Mar; 241(12):1251-3. PubMed ID: 216821
[TBL] [Abstract][Full Text] [Related]
15. [Circadian variations of 17-hydroxycorticosteroids and of tetrahydro-11-deoxycortisol in the healthy man: effect of the continuous administration of metyrapone (SU 4885)].
Touitou Y; Bogdan A; Limal JM; Reinberg A
C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(13):913-5. PubMed ID: 811399
[TBL] [Abstract][Full Text] [Related]
16. The metyrapone test in pituitary dwarfs--the determination of serum cortisol and 11-deoxycortisol by high-performance liquid chromatography.
Ginalska-Malinowska M; Małunowicz E; Romer TE; Filipek M
Endokrynol Pol; 1987; 38(1):21-7. PubMed ID: 2828014
[No Abstract] [Full Text] [Related]
17. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma.
Tjeerdsma G; Sluiter WJ; Hew JM; Molenaar WM; de Lange WE; Dullaart RP
Eur J Endocrinol; 1996 Sep; 135(3):299-308. PubMed ID: 8890720
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of urinary tetrahydro-11-deoxycortisol analysis in endocrine tests of the adrenal cortex].
Sagara Y; Okatani Y
Nihon Rinsho; 1989 Dec; 48 Suppl():1203-5. PubMed ID: 2560066
[No Abstract] [Full Text] [Related]
19. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
[TBL] [Abstract][Full Text] [Related]
20. Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
Bonnet-Serrano F; Poirier J; Vaczlavik A; Laguillier-Morizot C; Blanchet B; Baron S; Guignat L; Bessiene L; Bricaire L; Groussin L; Assié G; Guibourdenche J; Bertherat J
Eur J Endocrinol; 2022 Aug; 187(2):315-322. PubMed ID: 35699971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
